Can a pill redress social and racial injustice?
“The heart of a lot of what I do in the law is looking at intersections between law and science with specific attention to how it impacts issues of racial justice,” says Jonathan Kahn, a recently appointed professor of law and biology at Northeastern. That’s exactly what he’s done with his examination of the first race-based prescription drug in the U.S.
